Marksans Pharma Profile
Key Indicators
- Authorised Capital ₹ 69.00 Cr
- Paid Up Capital ₹ 45.32 Cr
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 226.00 Cr
- Satisfied Charges ₹ 337.16 Cr
- Revenue Growth 2.16%
- Profit Growth -1.08%
- Ebitda -19.18%
- Net Worth 41.63%
- Total Assets 39.28%
About Marksans Pharma
Marksans Pharma Limited (MPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 16 April 1992 and has a history of 32 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524404 and on the National Stock Exchange(NSE) under MARKSANS.
The Corporate was formerly known as Tasc Industries (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 69.00 Cr and a paid-up capital of Rs 45.32 Cr.
The company currently has active open charges totaling ₹226.00 Cr. The company has closed loans amounting to ₹337.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Marksans Pharma Limited India are Harshavardhan Panigrahi as COMPANY SECRETARY and Jitendra Sharma as Cfo. Abhinna Sundar, Sandra Saldanha, Digant Parikh, and Five other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
What products or services does Marksans Pharma Limited offer?
Marksans Pharma Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Immunomodulator Drugs, Sexual Wellness Products, Fertility Enhancer, Cardiovascular Drugs & Medication, Diabetes Medicine, Cardiac Drugs, Common Disease Medicines, IV Fluids.
Marksans Pharma Limited
Explore comprehensive data for Marksans Pharma Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Marksans Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshavardhan Panigrahi  | Company Secretary | 16-Feb-2009 | Current |
| Jitendra Sharma | CFO | 12-Aug-2014 | Current |
| Mark Saldanha | Managing Director | 06-Oct-2015 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Digant Parikh | Director | 14-Mar-2018 | Current |
| Abhinna Sundar | Director | 11-Jul-2019 | Current |
| Sandra Saldanha | Whole-Time Director | 25-Sep-2014 | Current |
| Sunny Sharma | Director | 11-Aug-2021 | Current |
| Seetharama Buddharaju | Director | 05-Oct-2011 | Current |
| Varddhman Jain | Whole-Time Director | 24-Jan-2019 | Current |
Financial Performance of Marksans Pharma.
Marksans Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.16% increase. The company also saw a slight decrease in profitability, with a 1.08% decrease in profit. The company's net worth Soared by an impressive increase of 41.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marksans Pharma?
In 2023, Marksans Pharma had a promoter holding of 43.85% and a public holding of 56.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innvolution Healthcare Private LimitedSunny Sharma is a mutual person
Innovation Imaging Technologies Private LimitedSunny Sharma is a mutual person
Orbimed Advisors India Private LimitedSunny Sharma is a mutual person
Innvolution Healthcare Private LimitedSunny Sharma is a mutual person
Adret Retail Private LimitedSunny Sharma is a mutual person
Advanced Enzyme Technologies LimitedSunny Sharma is a mutual person
Charges (Loans)
Open Charges
₹226.00 Cr
Satisfied Charges
₹337.16 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 226.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2006 | State Bank Of India | ₹226.00 Cr | Open |
| 07 Sep 2017 | State Bank Of India | ₹66.80 Cr | Satisfied |
| 23 Jun 2015 | State Bank Of India | ₹44.41 Cr | Satisfied |
| 23 Dec 2013 | Bank Of India | ₹4.00 Cr | Satisfied |
| 13 Aug 2010 | Bank Of India | ₹6.00 Cr | Satisfied |
How Many Employees Work at Marksans Pharma?
Marksans Pharma has a workforce of 95 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marksans Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marksans Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Marksans Pharma
Recent activity within the organization
- Annual General Meeting
Marksans Pharma Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records.
- Balance Sheet
Marksans Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 07 Sep 2017 via Charge ID 100125187 with State Bank Of India was fully satisfied on 29 Oct 2021.
- Director Appointment
Sunny Sharma was appointed as a Director was appointed as a Director on 11 Aug 2021 & has been associated with this company since 3 years 8 months .
- Director Appointment
Abhinna Mohanty Sundar was appointed as a Director was appointed as a Director on 11 Jul 2019 & has been associated with this company since 5 years 9 months .
- Director Appointment
Varddhman Vikramaditya Jain was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 24 Jan 2019 & has been associated with this company since 6 years 2 months .
Recent News, Updates & Announcement
- Marksans Pharma gets EIR from USFDA for its Goa facility.
The Mumbai-headquartered firm is engaged in research, manufacturing and marketing of generic pharmaceutical formulations in the global markets. .
- Marksans Pharma gets 8 observations from USFDA for its Goa facility.
The United States Food and Drug Administration (USFDA) has concluded inspection of company's Goa plant, Marksans Pharma said in a filing to BSE. .
- Marksans Pharma arm recalls unspecified number of Ibuprofen tablets from US.
The reason for recall is " various strengths of Ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies," latest enforcement report of the US health regulator said..
Frequently asked questions
What is the Incorporation or founding date of Marksans Pharma Limited?
Marksans Pharma Limited was incorporated on 16 Apr 1992.
What is authorized share capital and paid-up capital of Marksans Pharma Limited?
The authorized share capital of Marksans Pharma Limited is ₹ 69.00 Cr and paid-up capital is ₹ 45.32 Cr.
Who are the current board members & directors of Marksans Pharma Limited?
Currently 10 directors are associated with Marksans Pharma Limited.
- Abhinna Mohanty Sundar
- Sandra Saldanha
- Digant Mahesh Parikh
- Sunny Sharma
- Seetharama Raju Buddharaju
- Varddhman Vikramaditya Jain
- Shailaja Vardhan
- Harshavardhan Panigrahi
- Jitendra Mahabir Prasad Sharma
- Mark Saldanha
What is the registered address of Marksans Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Marksans Pharma Limited is 11Th Floor Grandeur Veera Desai Extension Road Oshiwara, Andheri (W) India, Mumbai, Maharashtra, 400053.
What is the corporate identification number (CIN) and company number of Marksans Pharma Limited?
The corporate identification number (CIN) of Marksans Pharma Limited is L24110MH1992PLC066364 and the company number is 066364 as per Ministry of Corporate Affairs (MCA).
Is Marksans Pharma Limited registered with any stock exchange in India?
Yes, Marksans Pharma Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): MARKSANS.
What is the official website of Marksans Pharma Limited?
The Official website of Marksans Pharma Limited is https://www.marksanspharma.com
What has been the recent revenue trend for Marksans Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Marksans Pharma Limited has risen by 2.16%.
How many employees does Marksans Pharma Limited currently have?
As Per 2023 financial reports, 95 employees are currently employed by Marksans Pharma Limited.
What change has been observed in the net worth of Marksans Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Marksans Pharma Limited has experienced an upsurge of 41.63%.
What are the total open charges for Marksans Pharma Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Marksans Pharma Limited amount to ₹ 226.00 Cr.
When was the last Balance Sheet of Marksans Pharma Limited filed with the ROC?
The most recent Balance Sheet for Marksans Pharma Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Kumar NairDirectorAM
Ajay MittalDirectorNV
Nagaraj ViswanathanDirectorMP
Mahesh ParikhDirectorAJ
Ajay JoshiDirectorKS
Kim SzeDirectorNW
Naresh WadhwaDirectorVN
Vinay NayakWholetime Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India